Klinische Neurophysiologie 2011; 42(2): 92-96
DOI: 10.1055/s-0031-1275655
Originalia

© Georg Thieme Verlag KG Stuttgart · New York

Diagnostik und Therapie des Baroreflexversagens

Diagnosis and Treatment of Baroreflex FailureJ. Jordan1
  • 1Institut für Klinische Pharmakologie, Hannover
Further Information

Publication History

Publication Date:
14 June 2011 (online)

Zusammenfassung

Der gesunde Baroreflex verhindert exzessive Fluktuationen des Blutdrucks. Eine beidseitige Schädigung von Barorezeptoren der großen Gefäße oder der Baroreflexafferenzen kann Baroreflexversagen verursachen. Häufigtse Ursache sind ausgedehnte chirurgische Eingriffe und Strahlentherapie im Halsbereich. Das führende klinische Symptom bei Baroreflexversagen ist eine zum Teil schwere arterielle Hypertonie mit stark schwankenden Blutdruckwerten. Blutdruckanstiege werden häufig durch psychische oder körperliche Belastung oder auch durch Schmerzreize getriggert. Einige Patienten leiden typischerweise in Ruhe unter episodenhaft auftretender Hypotonie und Bradykardie. Die Patienten benötigen eine Kombinationstherapie, die einerseits die Hypertonie vermindert und andererseits Hypotonie und Bradykardien vermindert.

Abstract

Healthy baroreflexes prevent excessive blood pressure swings. Bilateral damage to baro­receptors in large arteries or baroreflex afferents can cause baroreflex failure. The leading causes are extensive surgery and radiation of the neck. The prominent clinical feature of baroreflex fail­ure is often severe arterial hypertension with ­large blood pressure swings. Hypertensive episodes can be triggered by psychological stress, physical exercise, and pain. A minority of baroreflex failure patients presents with episodes of hypotension and bradycardia. Some patients also experience hypotensive and bradycardic episodes that typically occur rest. Patients may require a combination of treatments that diminish hypertensive episodes, attenuate hypotension, and prevent bradycardia.

Literatur

  • 1 Cowley AJ, Liard JF, Guyton AC. Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs.  Circ Res. 1973 May;  32 (5) 564-576
  • 2 Krieger EM. Neurogenic hypertension in the rat.  Circ Res. 1964 December;  15 511-521
  • 3 Thrasher TN. Unloading arterial baroreceptors causes neurogenic ­hypertension.  Am J Physiol Regul Integr Comp Physiol. 2002 April;  282 (4) R1044-R1053
  • 4 Lohmeier TE, Irwin ED, Rossing MA. et al . Prolonged activation of the baroreflex produces sustained hypotension.  Hypertension. 2004 ­February;  43 (2) 306-311
  • 5 Heusser K, Tank J, Engeli S. et al . Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.  Hypertension. 2010 March;  55 (3) 619-626
  • 6 Scheffers IJ, Kroon AA, Schmidli J. et al . Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study.  J Am Coll Cardiol. 2010 October 5;  56 (15) 1254-1258
  • 7 Robertson D, Hollister AS, Biaggioni I. et al . The diagnosis and treatment of baroreflex failure.  N Engl J Med. 1993;  329 (20) 1449-1455
  • 8 Ford FR. Fatal hypertensive crisis following denervation of the carotid sinus for the relief of repeated attacks of syncope.  Johns Hopkins Med J. 1956;  100 14-16
  • 9 Aksamit TR, Floras JS, Victor RG. et al . Paroxysmal hypertension due to sinoaortic baroreceptor denervation in humans.  Hypertension. 1987 March;  9 (3) 309-314
  • 10 Biaggioni I, Whetsell WO, Jobe J. et al . Baroreflex failure in a patient with central nervous system lesions involving the nucleus tractus solitarii.  Hypertension. 1994 April;  23 (4) 491-495
  • 11 Jordan J, Shannon JR, Black B. et al . Malignant vagotonia due to selective baroreflex failure.  Hypertension. 1997 November;  30 (5) 1072-1077
  • 12 Ketch T, Biaggioni I, Robertson R. et al . Four Faces of Baroreflex Failure: Hypertensive Crisis, Volatile Hypertension, Orthostatic Tachycardia, and Malignant Vagotonia.  Circulation. 2002 May 28;  105 (21) 2518-2523
  • 13 Heusser K, Tank J, Luft FC. et al . Baroreflex failure.  Hypertension. 2005 May;  45 (5) 834-839
  • 14 Timmers HJ, Karemaker JM, Lenders JW. et al . Baroreflex failure following radiation therapy for nasopharyngeal carcinoma.  Clin Auton Res. 1999 December;  9 (6) 317-324
  • 15 Guasti L, Simoni C, Scamoni C. et al . Mixed cranial nerve neuroma revealing itself as baroreflex failure.  Auton Neurosci. 2006 December 30;  130 (1–2) 57-60
  • 16 Jordan J, Tank J, Shannon JR. et al . Baroreflex Buffering and Susceptibility to Vasoactive Drugs.  Circulation. 2002 March 26;  105 (12) 1459-1464
  • 17 Lampen H, Kezdi P, Koppermann E. et al . Experimenteller Entzügelungshochdruck bei arterieller Hypertonie.  Zeitschrift für Kreislaufforschung. 1949;  38 577-592
  • 18 Fagius J, Wallin BG, Sundlof G. et al . Sympathetic outflow in man after anaesthesia of the glossopharyngeal and vagus nerves.  Brain. 1985;  108 (Pt 2) 423-438
  • 19 Krieger EM. Neurogenic hypertension in the rat.  Circ Res. 1964 December;  15 511-521
  • 20 Rothwell PM, Howard SC, Dolan E. et al . Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.  Lancet. 2010 March 13;  375 (9718) 895-905
  • 21 Berganzo K, Ciordia R, Gomez-Esteban JC. et al . Tako-tsubo cardiomyopathy in a patient with bilateral lesions in the dorsal medulla.  Clin Auton Res. 2010 October 21; 
  • 22 Bertinieri G, Di Rienzo M, Cavallazzi A. et al . Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats.  Am J Physiol. 1988 February;  254 (2 Pt 2) 377-383
  • 23 deBoer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model.  American Journal of Physiology. 1987 September;  253 (3 Pt 2) H680-H689
  • 24 Tank J, Baevski RM, Fender A. et al . Reference values of indices of spontaneous baroreceptor reflex sensitivity.  Am J Hypertens. 2000;  13 268-275
  • 25 La Rovere MT, Bigger JT, Marcus FI. et al . Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.  Lancet. 1998 February 14;  351 (9101) 478-484
  • 26 Timmers HJ, Karemaker JM, Wieling W. et al . Baroreflex control of muscle sympathetic nerve activity after carotid body tumor resection.  Hypertension. 2003 August;  42 (2) 143-149

Korrespondenzadresse

Prof. Dr. med. J. Jordan

Institut für Klinische

Pharmakologie

Medizinische Hochschule

Hannover

Carl-Neuberg-Straße 1

30625 Hannover

Email: jordan.jens@mh-hannover.de

URL: http://www.mh-hannover.de/klinpharm.html

    >